
Calls to immediately ban stock trading by members of Congress have surged, reigniting a fierce debate over ethics and insider trading in Washington. On September 7, 2025, bipartisan lawmakers, led by Rep. Abigail Spanberger (D-Va.) and Sen. Jon Ossoff (D-Ga.), renewed efforts to pass the STOCK Act 2.0, which would prohibit lawmakers, their spouses, and senior staff from trading individual stocks. The push follows allegations of suspicious trades by high-profile figures, including former House Speaker Nancy Pelosi, whose husband’s stock deals reportedly netted millions.
Proponents argue that lawmakers’ access to privileged information creates conflicts of interest, undermining public trust. A 2024 study found that congressional portfolios often outperform the market, with some lawmakers achieving returns 20% above average. Spanberger emphasized that banning trades would ensure legislators prioritize constituents over personal gain. The proposal includes strict penalties and mandatory divestment into blind trusts.
Opponents, including some Republican and Democratic lawmakers, argue the ban infringes on personal freedom and that existing disclosure rules are sufficient. They claim diversified investments mitigate conflicts and point to the STOCK Act of 2012, which requires trade disclosures within 45 days. Critics counter that enforcement remains weak, with only 11% of 2023 violations penalized.
Public support for a ban is strong, with a YouGov poll showing 68% of Americans in favor. Yet, resistance in Congress persists, with Senate leaders citing logistical challenges. As pressure mounts, the issue could shape voter sentiment ahead of the 2026 midterms, spotlighting transparency in governance.